Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility
Posted by
www.biotecnika.org
The company's topical manufacturing facility at Ahmedabad has received
an EIR from the United States Food and Drug Administration (USFDA)
signifying the successful closure of the audit, Cadila Healthcare said
in a filing to the BSE. The facility completed the USFDA audit from
December 16 to 20, 2019 with zero 483 observations, it added.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cadila-healthcare-gets-eir-from-usfda-for-its-ahmedabad-facility/articleshow/74063106.cms
Subscribe to:
Post Comments (Atom)
May 7, 2023 at 8:18 PM
There are numerous ways to amuse ourselves, such as playing online games. I typically play
run 3 after every working hour; it's a highly captivating and captivating endless runner game.
Post a Comment